SCGB1A1 and chronic obstructive pulmonary disease: While considering all the COPD subjects (n = 100; BMS-COPD and TS-COPD), levels of SCGB1A1 decreased with an increased severity of COPD (GOLD stages I–IV; Figure 3k) and dyspnea (mMRC; Figure 3l).